About Linear Diagnostics
Linear Diagnostics is a company based in Birmingham (United Kingdom) founded in 2011 by Matthew Hicks. Linear Diagnostics has raised $4.08 million across 4 funding rounds from investors including Abingdon Health, British Business Bank and The University Of Birmingham. The company has 4 employees as of January 31, 2022. Linear Diagnostics offers products and services including Linear Dichroism Technology and EXPAR System. Linear Diagnostics operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
- Headquarter Birmingham, United Kingdom
- Employees 4 as on 31 Jan, 2022
- Founders Matthew Hicks
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Linear Diagnostics Limited
- Date of Incorporation 29 Mar, 2011
- Jurisdiction NOTTINGHAM, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.08 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Abingdon Health
& 6 more
-
Employee Count
4
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Linear Diagnostics
Linear Diagnostics offers a comprehensive portfolio of products and services, including Linear Dichroism Technology and EXPAR System.
Enables rapid and accurate detection of sexually transmitted infections at point of care.
Facilitates quick testing for multiple infectious diseases in under 15 minutes.
People of Linear Diagnostics
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Linear Diagnostics
Linear Diagnostics has successfully raised a total of $4.08M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Linear Diagnostics
Linear Diagnostics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Abingdon Health, British Business Bank and The University Of Birmingham.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage UK companies are invested in by Midven.
|
Locked | Locked | Locked | |
|
Investment funding is provided to support Midlands SMEs growth.
|
Locked | Locked | Locked | |
|
Early-stage innovations are funded by UKI2S across key sectors.
|
Locked | Locked | Locked |
Investor details for Linear Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Linear Diagnostics
Investment portfolio details for Linear Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Linear Diagnostics
Detailed financials for Linear Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Linear Diagnostics Comparisons
Peer comparison for Linear Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Linear Diagnostics
Linear Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
Detailed competitors of Linear Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Linear Diagnostics
Complete news archive for Linear Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Linear Diagnostics
Linear Diagnostics was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Linear Diagnostics is headquartered in Birmingham, United Kingdom. It is registered at Birmingham, England, United Kingdom.
Brendan Farrell is the current CEO of Linear Diagnostics.
Linear Diagnostics is a funded company, having raised a total of $4.08M across 4 funding rounds to date.
As of Jan 31, 2022, the latest employee count at Linear Diagnostics is 4.
Linear Diagnostics was founded in 2011 in Birmingham, United Kingdom, within the biotechnology sector. Molecular diagnostic tests for sexually transmitted infections are developed, focusing on Chlamydia trachomatis and Neisseria gonorrhoeae. An optical system that integrates linear dichroism with disposable cartridges and instruments is utilized. Gene sequences are detected through this dual-test approach, supporting clinical diagnostics in the medical field.
Linear Diagnostics's top competitors include Visby Medical, Inflammatix and MeMed.
Linear Diagnostics offers Linear Dichroism Technology and EXPAR System.
Linear Diagnostics has 7 investors. Key investors include Abingdon Health, British Business Bank, The University Of Birmingham, Future Planet Capital Regional, and NIHR.
The valuation of Linear Diagnostics is $2.61M as of Sep 2019.